Skip to main content

Our Resources

Below you'll find case studies, webinars, blogs, and press releases where we share valuable insights about decentralized clinical trials.

Featured
Press Release

SPRIM PRO and ObvioHealth Expand Collaboration to Deliver Digitally Enabled Trials with Scientific Rigor and Global Reach

› Read More
Featured
Blog

ObvioHealth’s Role in the FDA’s Push for Infant Formula Innovation: A Case for Decentralized Trials

› Read More
Filter Category
Clear
Filter Category
Clear
White Paper

Overcoming Research Challenges in Depression

Depression clinical studies are rife with roadblocks. Learn how digital and remote methods can help to circumvent them.

› Read More
Press Release

ObvioHealth Signs R&D Partnership with A*STAR to Identify and Develop Novel Digital Biomarkers

› Read More
Blog

CNS Clinical Trials: How DCT Solutions Address 4 Key Challenges in CNS Research

The challenges associated with conducting central nervous system clinical research all impact sponsors’ and study teams’ ability to gather stronger therapeutic evidence—but they also prime CNS studies for decentralization.

› Read More
Playbook

Patient Engagement Strategies for Clinical Trials

A comprehensive look at tech-enabled, human-supported patient engagement protocols

› Read More
Press Release

ObvioHealth to Conduct a Pioneering Decentralized Clinical Trial on the Mi-Helper Device for Treatment of Migraine

ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for treatment of migraines.

› Read More
Press Release

ObvioHealth, IQVIA Consumer Health, and Jovie USA Launch Innovative At-Home Trial to Bring First Goat Milk-Based Infant Formula to the United States  

ObvioHealth, in partnership with IQVIA Consumer Health, announces the launch of a fully decentralized clinical trial with Jovie USA to bring an innovative goat milk-based infant formula to the United States.

› Read More
Blog

Remote Patient Monitoring: How RPM Delivers Stronger Clinical Trial Evidence

› Read More
Blog

Decentralized Clinical Trials and the FDA: What the FDA Regulatory Framework Means for DCTs

Many clinical trial sponsors don’t understand how decentralized clinical trials (DCTs) fit within today’s regulatory landscape. This lack of familiarity with decentralized research and regulatory approaches has created DCT hesitancy among sponsors.

› Read More
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.